Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort

INTRODUCTION: Lipopolysaccharide (LPS) is the outer membrane component of Gram-negative bacteria. LPS-binding protein (LBP) is an acute-phase reactant that mediates immune responses triggered by LPS and has been used as a blood marker for LPS. LBP has recently been indicated to be associated with Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yujia, Walker, Douglas I., Lill, Christina M., Bloem, Bastiaan R., Darweesh, Sirwan K. L., Pinto-Pacheco, Brismar, McNeil, Brooklyn, Miller, Gary W., Heath, Alicia K., Frissen, Myrthe, Petrova, Dafina, Sánchez, Maria-Jose, Chirlaque, María-Dolores, Guevara, Marcela, Zibetti, Maurizio, Panico, Salvatore, Middleton, Lefkos, Katzke, Verena, Kaaks, Rudolf, Riboli, Elio, Masala, Giovanna, Sieri, Sabina, Zamora-Ros, Raul, Amiano, Pilar, Jenab, Mazda, Peters, Susan, Vermeulen, Roel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362572/
https://www.ncbi.nlm.nih.gov/pubmed/37480114
http://dx.doi.org/10.1186/s12974-023-02846-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362572/
https://www.ncbi.nlm.nih.gov/pubmed/37480114
http://dx.doi.org/10.1186/s12974-023-02846-2

Ejemplares similares